Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05821842 · ClinicalTrials.gov registry record · NA
Sonu Nasal Congestion Relief Study in Patients Suffering From Moderate to Severe Nasal Congestion
A NA study of Nasal Congestion and Inflammations, sponsored by Third Wave Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT05821842 is a NA study of Nasal Congestion and Inflammations that has completed, run by Third Wave Therapeutics. The registered enrollment target is 52 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05821842, a NA study of Nasal Congestion and Inflammations, has completed, sponsored by Third Wave Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
To demonstrate the safety and effectiveness of Sonu for the treatment of patients suffering from moderate to severe nasal congestion.
Conditions Studied
Interventions
- DEVICE Sonu
Study Locations (1)
California
- San Francisco Otolaryngology Medical Group - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2022-03-23 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05821842
The ClinicalTrials.gov registry entry for NCT05821842 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Third Wave Therapeutics, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nasal Congestion and Inflammations appearing as the primary indexed condition, and to 1 intervention - of which Sonu is the first listed.
NCT05821842 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05821842 about?
NCT05821842 is a clinical study titled "Sonu Nasal Congestion Relief Study in Patients Suffering From Moderate to Severe Nasal Congestion". To demonstrate the safety and effectiveness of Sonu for the treatment of patients suffering from moderate to severe nasal congestion.
What is the current status of trial NCT05821842?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2022-03-23. Estimated completion is 2023-06-30.
What conditions does trial NCT05821842 study?
This clinical trial studies the following conditions: Nasal Congestion and Inflammations.
What interventions are being tested in trial NCT05821842?
The interventions under investigation include: Sonu (DEVICE).
Who is sponsoring clinical trial NCT05821842?
This trial is sponsored by Third Wave Therapeutics, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05821842 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nasal Congestion and Inflammations
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.